Efficacy and gastrointestinal safety of selective COX-2 inhibitors
Publisher
Birkhäuser Basel
Reference79 articles.
1. Girgis L, Brooks P (1994) Nonsteroidal anti-inflammatory drugs. Differential use in older patients. Drugs Aging 4: 101–112
2. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231: 232–235
3. Roth GJ, Stanford N, Majerus PW (1975) Acetylation of prostaglandin synthetase by aspirin. Proc Natl Acad Sci USA 72: 3073–3076
4. Henry D, Lim LL, Garcia-Rodriguez LA, Perez Gutthann S, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C et al (1996) Variability in risk of gastrointestinal complications with individual non-steroidal antiinflammatory drugs: results of a collaborative meta-analysis. BMJ 312: 1563–1566
5. Singh G, Ramey DR, Morfeld D, Fries JF (1994) Comparative toxicity of non-steroidal antiinflammatory agents. Pharmacol Ther 62: 175–191